Literature DB >> 20788241

ANNOTATIONS.

.   

Abstract

Year:  1954        PMID: 20788241      PMCID: PMC2084935     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Report on mysoline in the treatment of mental hospital epileptics.

Authors:  B G BURTON-BRADLEY
Journal:  Med J Aust       Date:  1953-11-07       Impact factor: 7.738

2.  Primidone in the treatment of non-idiopathic epilepsy.

Authors:  P W NATHAN
Journal:  Lancet       Date:  1954-01-02       Impact factor: 79.321

3.  Mysoline, its use in epilepsy.

Authors:  J A GAME
Journal:  Med J Aust       Date:  1953-11-07       Impact factor: 7.738

4.  Mysoline: a clinical evaluation of a new drug in the treatment of refractory cases of epilepsy.

Authors:  G SELBY
Journal:  Med J Aust       Date:  1953-11-07       Impact factor: 7.738

5.  Treatment of epilepsy with mysoline.

Authors:  L GREENSTEIN; M R SAPIRSTEIN
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-10

6.  Value of primidone in epilepsy.

Authors:  C W WHITTY
Journal:  Br Med J       Date:  1953-09-05

7.  Mysoline in the treatment of epilepsy.

Authors:  A J M BUTTER
Journal:  Lancet       Date:  1953-05-23       Impact factor: 79.321

8.  Mysoline; a new drug in the treatment of epilepsy.

Authors:  R HANDLEY; A S STEWART
Journal:  Lancet       Date:  1952-04-12       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.